Consequences of nongenomic actions of estradiol on pathogenic genital tract response

Journal of Molecular Signaling

Luis Velasquez¹  Paula Solar¹ 

[1] Centro para el desarrollo de la nanociencia y la nanotecnología (CEDENNA), Santiago, Chile

关键词: Immune response;    Pathogenesis;    Genital tract;    Nongenomic;    Estradiol;   

Others  :  802756
DOI  :  10.1186/1750-2187-8-1

 received in 2012-12-07, accepted in 2013-01-24,  发布年份 2013

【 摘 要 】

Estradiol is a steroid hormone that regulates the structure and function of the female reproductive system. In addition to its genomic effects, which are mediated by activated nuclear receptors, estradiol elicits a variety of rapid signaling events independently of transcriptional or genomic regulation. These nongenomic actions influence the milieu of the genital tract, which changes the ability of pathogens to infect the genital tract. This review discusses our current knowledge regarding the mechanisms and relevance of nongenomic estradiol signaling in the genital tract that could change the ability of pathogens to invade epithelial cells. PubMed was searched through January 1980 for papers related to estradiol actions in the ovary, fallopian tube, uterus and cervix. The mechanisms conveying these rapid effects consist of a multitude of signaling molecules and include cross-talk with slower transcriptional actions. The nongenomic actions of estradiol that influence the infectious abilities of pathogens occur either directly on the genital tract cells or indirectly by modulating the local and systemic immune systems. Additional in-depth characterization of the response is required before the normal and pathological reproductive functions of the nongenomic estradiol pathway can be targeted for pharmacological intervention.

【 授权许可】

   
2013 Solar and Velasquez; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Jaffe HW, Biddle JW, Johnson SR, Wiesner PJ: Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976–1980. J Infect Dis 1981, 144(2):1917-1981.
• [2]Da Ros CT, Schitt CdaS: Global epidemiology of sexually transmitted diseases. Asian J Androl 2008, 10(1):110-114.
• [3]Franchi A, Zaret J, Zhang X, Bocca S, Oehninger S: Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol Hum Reprod 2008, 14(7):413-421.
• [4]Kumar R, Zakharov MN, Khan SH, Miki R, Jang H, Toraldo G, Singh R, Bhasin S, Jasuja R: The dynamic structure of the estrogen receptor. Res J Amino Acids 2011, 201(1):812540.
• [5]Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY, Tsai MJ: Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 2010, 24(4):709-730.
• [6]O’Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994, 63:451-486.
• [7]Hammes SR, Levin ER: Extranuclear steroid receptors: nature and actions. Endocr Rev 2007, 28:726-741.
• [8]McDonnell DP, Norris JD: Connections and regulation of the human estrogen receptor. Science 2002, 296:1642-1644.
• [9]Hall JM, Couse JF, Korach KS: The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001, 276:36869-36872.
• [10]Segars JH, Driggers PH: Estrogen action and cytoplasmic signaling cascades. I. Membrane-associated signaling complexes. Trends Endocrinol Metab 2002, 13:349-354.
• [11]Björnström L, Sjöberg M: Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005, 19(4):833-842.
• [12]Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA: Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000, 183(4):967-973.
• [13]Fazelili A, Bruce C, Anumba DO: Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod 2005, 20(5):1372-1378.
• [14]Cramer H: Statistical studies on cell nuclear size variations in different histological forms of the vaginal cervical epithelium with special consideration of carcinoma. Arch Gynakol 1953, 182(4):461-496.
• [15]Hafez ES: In vivo and in vitro sperm penetration in cervical mucus. Acta Eur Fertil 1979, 10(2):41-50.
• [16]Gladdines MM, Ackermans MT, Everaerts FM: Analysis of the aqueous phase high-performance liquid chromatography and capillary isotachophoresis. J Chromutography 1988, 431:317-325.
• [17]Van Kooij RJ, Kathmann AM, Kramer MF: Secretory piece and plasma proteins in human cervical mucus during the cycle. Reprod Fert 1983, 68:63-68.
• [18]Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR: Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002, 168(5):2424-2432.
• [19]Fichorova RN, Anderson DJ: Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999, 60(2):508-522.
• [20]Ageawal T, Vats V, Wallace PK, Salhan S, Mittal A: Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection. Reprod Biol Endocrinol 2008, 6:46. BioMed Central Full Text
• [21]Forcelledo ML, de la Cerda ML, Croxatto HB: Effectiveness of different estrogen pulses in plasma for accelerating ovum transport and their relation to estradiol levels in the rat oviduct. Endocrinology 1986, 119(3):1189-1194.
• [22]Villalón M, Verdugo P: Hormonal regulation of ciliary function in the oviduct: the effect of beta-adrenergic agonists. Prog Clin Biol Res 1982, 80:59-65.
• [23]Priyadarsana M, Wijayagunawardane B, Miyamoto A: Endothelin-1 system in the bovine oviduct: a regulator of local contraction and gamete transport. J Cardiovasc Pharmacol 2004, 44(1):S248-S251.
• [24]Ríos M, Hermoso M, Sánchez TM, Croxatto HB, Villalón MJ: Effect of oestradiol and progesterone on the instant and directional velocity of microsphere movements in the rat oviduct: gap junctions mediate the kinetic effect of oestradiol. Reprod Fertil Dev 2007, 19(5):634-640.
• [25]Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Procc Natl Acad Sci USA 1994, 91(18):8517-8521.
• [26]Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schawartz JL: A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992, 131(3):1305-1312.
• [27]Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
• [28]Hirata T, Osuga Y, Hamasaki K, Hirota Y, Nose E, Morimoto C, Harada M, Takemura Y, Koga K, Yoshino O, Tajima T, Hasegawa A, Yano T, Taketani Y: Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007, 74(1–2):53-60.
• [29]Han JH, Kim MS, Lee MY, Kim TH, Lee MK, Kim HR, Myung SC: Modulation of human beta-defensin-2 expression by 17beta-estradiol and progesterone in vaginal epithelial cells. Cytokine 2010, 49(2):209-214.
• [30]Watson CS, Jeng YJ, Kochukov MY: Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 2008, 22(9):3328-3336.
• [31]Suzuki T, Yu HP, Hsieh YC, Choudhry MA, Bland KI, Chaudry JH: Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage. J Cell Physiol 2008, 214(3):662-672.
• [32]Crane-Godreau MA, Wira CR: Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infect Immun 2005, 73(7):4231-4237.
• [33]Suzuki T, Yu HP, Hsieh YC, Choudhry MA, Bland KI, Chaudry IH: Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage. Cytokine 2008, 42(1):32-40.
• [34]Pioli PA, Weaver LK, Schaefer TM, Wright JA, Wira CR, Guyre PM: Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2. J Immunol 2006, 176(11):6647-6655.
• [35]Lobanova YS, Scherbakov AM, Shatskaya VA, Krasil'nikov MA: Mechanism of estrogen-induced apoptosis in breast cancer cells: role of the NF-kappaB signaling pathway. Biochemistry (Mosc) 2007, 72(3):320-327.
• [36]Robinson LJ, Yaroslavskiy BB, Griswold RD, Zadorozny EV, Guo L, Tourkova IL, Blair HC: Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp Cell Res 2009, 315(7):1287-1301.
• [37]Jiang X, Ellison SJ, Alarid ET, Shapiro DJ: Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 2007, 26:4106-4114.
• [38]Wira CR, Rossoll RM, Kaushic C: Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology 2000, 141(8):2877-2885.
• [39]Brabin L: Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression, AIDS. Patient Care STDS 2002, 16(5):211-221.
• [40]Peddie BA, Bishop V, Bailey RR, MacGill H: Relationship between contraceptive method and vaginal flora. Obstet Gynaecol 1984, 24(3):217-225.
• [41]Fernandez R, Nelson P, Delgado J, Aguilera JA, Massai R, Velasquez L, Imarai M, Croxato HB, Cardenas H: Increased adhesiveness and internalization of Neisseria gonorrhoeae and changes in the expression of epitelial gonococcal recceptors in Fallopian tuve of copper T and Norplant ® users. Hum Reprod 2001, 16(3):463-468.
• [42]Jerse AE: Experimental Gonococcal Genital Tract Infection and Opacity Protein Expression in Estradiol-Treated Mice. Infect Immun 1999, 67(11):5699-5708.
• [43]Sonnex C: Influence of ovarian hormones on urogenital infection. Sex Transm Infect 1998, 74(1):11-19.
• [44]Gockel CM, Bao S, Holland MK, Beagley KW: Influence of the murine oestrous cycle on the induction of mucosal immunity. Am J Reprod Immunol 2003, 50(5):369-379.